Successful treatment of acquired von Willebrand syndrome secondary to low-grade CLL with rituximab and venetoclax

Affiliations

• ¹ University of Washington, Seattle, WA, USA.
• ² Fred Hutch Cancer Center, University of Washington, Seattle, WA, USA.
• ³ Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
• ⁴ Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.
• ⁵ Center for Cardiovascular Biology, University of Washington, Seattle, WA, USA.
• ⁶ Washington Center for Bleeding Disorders, Seattle, WA, USA.